全文获取类型
收费全文 | 2818篇 |
免费 | 137篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 140篇 |
妇产科学 | 73篇 |
基础医学 | 224篇 |
口腔科学 | 211篇 |
临床医学 | 156篇 |
内科学 | 766篇 |
皮肤病学 | 149篇 |
神经病学 | 154篇 |
特种医学 | 98篇 |
外科学 | 316篇 |
综合类 | 322篇 |
一般理论 | 2篇 |
预防医学 | 91篇 |
眼科学 | 29篇 |
药学 | 104篇 |
1篇 | |
中国医学 | 7篇 |
肿瘤学 | 110篇 |
出版年
2023年 | 10篇 |
2022年 | 34篇 |
2021年 | 50篇 |
2020年 | 33篇 |
2019年 | 37篇 |
2018年 | 40篇 |
2017年 | 39篇 |
2016年 | 45篇 |
2015年 | 87篇 |
2014年 | 97篇 |
2013年 | 121篇 |
2012年 | 150篇 |
2011年 | 161篇 |
2010年 | 158篇 |
2009年 | 118篇 |
2008年 | 134篇 |
2007年 | 135篇 |
2006年 | 140篇 |
2005年 | 124篇 |
2004年 | 158篇 |
2003年 | 102篇 |
2002年 | 86篇 |
2001年 | 74篇 |
2000年 | 84篇 |
1999年 | 65篇 |
1998年 | 46篇 |
1997年 | 43篇 |
1996年 | 41篇 |
1995年 | 25篇 |
1994年 | 35篇 |
1993年 | 14篇 |
1992年 | 39篇 |
1991年 | 33篇 |
1990年 | 48篇 |
1989年 | 33篇 |
1988年 | 30篇 |
1987年 | 34篇 |
1986年 | 28篇 |
1985年 | 24篇 |
1984年 | 21篇 |
1983年 | 12篇 |
1982年 | 25篇 |
1981年 | 11篇 |
1979年 | 16篇 |
1978年 | 17篇 |
1977年 | 15篇 |
1975年 | 11篇 |
1973年 | 10篇 |
1972年 | 9篇 |
1969年 | 18篇 |
排序方式: 共有2962条查询结果,搜索用时 15 毫秒
1.
2.
Endoscopic sclerotherapy in the treatment of gastric varices 总被引:4,自引:0,他引:4
Of 309 patients with portal hypertension, gastric varices were found in 48 (16 per cent). While the majority (88 per cent) of the patients had gastric varices in association with oesophageal varices, 6 (12 per cent) patients had 'isolated' gastric varices. Gastric varices were seen significantly (P less than 0.01) more often with grade 4 than with grade 3 varices. In 11 (28 per cent) of the 40 patients who completed sclerotherapy for oesophageal varices, gastric varices disappeared concurrently on eradication of oesophageal varices or during the following 6 months. Of the initial five patients with gastric varices who received direct intravariceal injections, four rebled; this technique was therefore replaced by combination (paravariceal + intravariceal) gastric variceal sclerotherapy. Emergency combination sclerotherapy successfully controlled bleeding from gastric varices in six of the eight treated patients. Thirty-two patients entered a programme of elective combination gastric variceal sclerotherapy. Variceal obliteration was achieved in 12 cases (38 per cent) and reduction in size was noted in another 7 patients (22 per cent) after a minimum of four courses. There were 11 (23 per cent) deaths, 8 due to uncontrolled bleeding from gastric varices and 3 due to hepatic coma. The other complications of gastric variceal sclerotherapy were minor and included retrosternal pain, fever and dysphagia. It is concluded that gastric varices often coexist with large oesophageal varices. If they persist for 6 months after eradication of oesophageal varices, a combination of paravariceal and intravariceal sclerotherapy should be attempted for their obliteration. 相似文献
3.
4.
5.
6.
7.
Stöhr H Marquardt A Nanda I Schmid M Weber BH 《European journal of human genetics : EJHG》2002,10(4):281-284
The RFP-TM protein family was first described in Caenorhabditis elegans as hypothetical transmembrane proteins containing a conserved 350-400 amino acid domain including the invariant peptide motif RFP. The VMD2 gene underlying Best disease was shown to represent the first human member of the RFP-TM protein family. More than 97% of the disease-causing mutations are located in the N-terminal RFP-TM domain implying important functional properties. Here, we have identified three novel VMD2-related human genes (VMD2L1, VMD2L2 and VMD2L3) demonstrating a high degree of conservation in their respective RFP-TM domains. Each of the VMD2-like proteins has a unique C-terminus that lack similarity to other proteins or motifs. By FISH analysis, VMD2L1 was localised to chromosome 19p13.2-p13.12, VMD2L2 to 1p32.3-p33 and VMD2L3 to 12q14.2-q15. RT-PCR analyses revealed tissue-restricted expression of the three genes with both VMD2L1 and VMD2L2 abundantly transcribed in colon. VMD2L1 is present in the retinal pigment epithelium while VMD2L3 shows predominant expression in skeletal muscle. 相似文献
8.
Tanja Vogel Holly Boettger-Tong Indrajit Nanda Frank Dechend Alexander I. Agulnik Colin E. Bishop Michael Schmid Jorg Schmidtke 《Chromosome research》1998,6(1):35-40
Sequences homologous to human and bovine TSPY were isolated from M. musculus testicular cDNA, and a nearly full-length gene was polymerase chain reaction (PCR) amplified from mouse genomic DNA. This gene is apparently non-functional. Contrary to the situation encountered in species along the primate and artiodactyl lineages, in which TSPY is moderately repetitive, murine Tspy appears to be single copy. Murine Tspy is located on Yp, i.e. in the same syntenic group as in man. Sequence comparisons of murine, human and bovine TSPY exons suggest that TSPY became non-functional during rodent evolution. 相似文献
9.
Carlos R Ferreira Dillon Kavanagh Ralf Oheim Kristin Zimmerman Julian Stürznickel Xiaofeng Li Paul Stabach R Luke Rettig Logan Calderone Colin MacKichan Aaron Wang Hunter A Hutchinson Tracy Nelson Steven M Tommasini Simon von Kroge Imke AK Fiedler Ethan R Lester Gilbert W Moeckel Björn Busse Thorsten Schinke Thomas O Carpenter Michael A Levine Mark C Horowitz Demetrios T Braddock 《Journal of bone and mineral research》2021,36(5):942-955
Inactivating mutations in human ecto-nucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) may result in early-onset osteoporosis (EOOP) in haploinsufficiency and autosomal recessive hypophosphatemic rickets (ARHR2) in homozygous deficiency. ARHR2 patients are frequently treated with phosphate supplementation to ameliorate the rachitic phenotype, but elevating plasma phosphorus concentrations in ARHR2 patients may increase the risk of ectopic calcification without increasing bone mass. To assess the risks and efficacy of conventional ARHR2 therapy, we performed comprehensive evaluations of ARHR2 patients at two academic medical centers and compared their skeletal and renal phenotypes with ENPP1-deficient Enpp1asj/asj mice on an acceleration diet containing high phosphate treated with recombinant murine Enpp1-Fc. ARHR2 patients treated with conventional therapy demonstrated improvements in rickets, but all adults and one adolescent analyzed continued to exhibit low bone mineral density (BMD). In addition, conventional therapy was associated with the development of medullary nephrocalcinosis in half of the treated patients. Similar to Enpp1asj/asj mice on normal chow and to patients with mono- and biallelic ENPP1 mutations, 5-week-old Enpp1asj/asj mice on the high-phosphate diet exhibited lower trabecular bone mass, reduced cortical bone mass, and greater bone fragility. Treating the Enpp1asj/asj mice with recombinant Enpp1-Fc protein between weeks 2 and 5 normalized trabecular bone mass, normalized or improved bone biomechanical properties, and prevented the development of nephrocalcinosis and renal failure. The data suggest that conventional ARHR2 therapy does not address low BMD inherent in ENPP1 deficiency, and that ENPP1 enzyme replacement may be effective for correcting low bone mass in ARHR2 patients without increasing the risk of nephrocalcinosis. © 2021 American Society for Bone and Mineral Research (ASBMR). 相似文献
10.